Spotlight on Vertex Pharmaceuticals: Analyzing the Surge in Options Activity
Spotlight on Vertex Pharmaceuticals: Analyzing the Surge in Options Activity
Financial giants have made a conspicuous bullish move on Vertex Pharmaceuticals. Our analysis of options history for Vertex Pharmaceuticals (NASDAQ:VRTX) revealed 16 unusual trades.
金融巨頭對Vertex Pharmicals採取了明顯的看漲舉動。我們對Vertex Pharmicals（納斯達克股票代碼：VRTX）期權歷史的分析顯示了16筆不尋常的交易。
Delving into the details, we found 56% of traders were bullish, while 25% showed bearish tendencies. Out of all the trades we spotted, 4 were puts, with a value of $155,386, and 12 were calls, valued at $721,286.
深入研究細節後，我們發現56％的交易者看漲，而25％的交易者表現出看跌趨勢。在我們發現的所有交易中，有4筆是看跌期權，價值爲155,386美元，12筆是看漲期權，價值721,286美元。
Projected Price Targets
預計價格目標
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $340.0 to $470.0 for Vertex Pharmaceuticals over the recent three months.
根據交易活動，看來重要投資者的目標是在最近三個月中將Vertex Pharmicals的價格區間從340.0美元擴大到470.0美元。
Volume & Open Interest Development
交易量和未平倉合約的發展
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Vertex Pharmaceuticals's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Vertex Pharmaceuticals's whale trades within a strike price range from $340.0 to $470.0 in the last 30 days.
在交易期權時，查看交易量和未平倉合約是一個強有力的舉動。這些數據可以幫助您跟蹤Vertex Pharmicals期權在給定行使價下的流動性和利息。下面，我們可以觀察過去30天中Vertex Pharmicals所有鯨魚交易的看漲和看跌期權交易量和未平倉合約的分別變化，其行使價在340.0美元至470.0美元之間。
Vertex Pharmaceuticals Option Activity Analysis: Last 30 Days
Vertex Pharmicals 期權活動分析：過去 30 天
Significant Options Trades Detected:
檢測到的重要期權交易：
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| VRTX | CALL | TRADE | BULLISH | 06/21/24 | $94.0 | $89.4 | $94.0 | $360.00 | $235.0K | 197 | 25 |
| VRTX | CALL | TRADE | BULLISH | 01/17/25 | $83.5 | $79.0 | $83.5 | $390.00 | $91.8K | 83 | 11 |
| VRTX | CALL | TRADE | BULLISH | 06/21/24 | $30.0 | $28.0 | $30.0 | $425.00 | $51.0K | 0 | 17 |
| VRTX | CALL | TRADE | BULLISH | 01/17/25 | $34.0 | $31.4 | $33.69 | $470.00 | $50.5K | 141 | 16 |
| VRTX | CALL | TRADE | BULLISH | 06/21/24 | $94.5 | $90.2 | $94.5 | $360.00 | $47.2K | 197 | 30 |
| 符號 | 看跌/看漲 | 交易類型 | 情緒 | Exp。日期 | 問 | 出價 | 價格 | 行使價 | 總交易價格 | 未平倉合約 | 音量 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| VRTX | 打電話 | 貿易 | 看漲 | 06/21/24 | 94.0 美元 | 89.4 美元 | 94.0 美元 | 360.00 美元 | 235.0 萬美元 | 197 | 25 |
| VRTX | 打電話 | 貿易 | 看漲 | 01/17/25 | 83.5 美元 | 79.0 美元 | 83.5 美元 | 390.00 美元 | 91.8 萬美元 | 83 | 11 |
| VRTX | 打電話 | 貿易 | 看漲 | 06/21/24 | 30.0 美元 | 28.0 美元 | 30.0 美元 | 425.00 美元 | 51.0 萬美元 | 0 | 17 |
| VRTX | 打電話 | 貿易 | 看漲 | 01/17/25 | 34.0 美元 | 31.4 美元 | 33.69 美元 | 470.00 美元 | 50.5 萬美元 | 141 | 16 |
| VRTX | 打電話 | 貿易 | 看漲 | 06/21/24 | 94.5 美元 | 90.2 美元 | 94.5 美元 | 360.00 美元 | 47.2 萬美元 | 197 | 30 |
About Vertex Pharmaceuticals
關於 Vertex 製藥
Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio for cystic fibrosis, where Vertex therapies remain the standard of care globally. Vertex has diversified its portfolio through Casgevy, a gene-editing therapy for beta thalassemia and sickle-cell disease. Additionally, Vertex is evaluating small-molecule inhibitors targeting acute and chronic pain using nonopioid treatments, and small-molecule inhibitors of APOL1-mediated kidney diseases. Vertex is also investigating cell therapies to deliver a potential functional cure for type 1 diabetes.
Vertex Pharmaceuticals是一家全球生物技術公司，致力於發現和開發用於治療嚴重疾病的小分子藥物。其主要藥物是治療囊性纖維化的Kalydeco、Orkambi、Symdeko和Trikafta/Kaftrio，其中Vertex療法仍然是全球的護理標準。Vertex通過Casgevy實現了其產品組合的多元化，Casgevy是一種治療β地中海貧血和鐮狀細胞病的基因編輯療法。此外，Vertex正在評估使用非阿片類藥物治療的針對急性和慢性疼痛的小分子抑制劑，以及針對APOL1介導的腎臟疾病的小分子抑制劑。Vertex還在研究細胞療法，爲1型糖尿病提供潛在的功能性治療方法。
Where Is Vertex Pharmaceuticals Standing Right Now?
Vertex Pharmicals 現在處於什麼位置？
- With a trading volume of 970,917, the price of VRTX is up by 0.47%, reaching $449.65.
- Current RSI values indicate that the stock is may be overbought.
- Next earnings report is scheduled for 68 days from now.
- VRTX的價格上漲了0.47％，達到449.65美元，交易量爲970,917美元。
- 當前的RSI值表明該股可能已被超買。
- 下一份收益報告定於即日起68天后發佈。
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
與僅交易股票相比，期權是一種風險更高的資產，但它們具有更高的獲利潛力。嚴肅的期權交易者通過每天自我教育、擴大交易規模、關注多個指標以及密切關注市場來管理這種風險。